Liangming M. Ma
Taiyuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Matching-Adjusted Indirect Comparison of Gecacitinib, Fedratinib, Pacritinib, and Momelotinib in Second-Line Myelofibrosis Therapy.
Journal: Hematological oncology
Published: April 27, 2026
Impact of frailty tools on outcomes in myeloma: MRP and simplified index predict survival but differ in infection risk stratification.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 09, 2026
Case Report: Short-course defibrotide combined with eculizumab for TA-TMA.
Journal: Frontiers in immunology
Published: December 19, 2025
Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data.
Journal: Blood science (Baltimore, Md.)
Published: July 01, 2025
Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome: A prospective multicenter clinical cohort study.
Journal: Chinese medical journal
Published: October 06, 2023
Analysis and clinical characteristics of acute myeloid leukemia developing with prior or concurrent tumors in non cyto- or radiotherapy exposure patients in a single center.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 10, 2023
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Journal: American journal of hematology
Published: June 02, 2023
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Journal: American journal of hematology
Published: June 02, 2023
Acute intestinal GVHD following donor-derived CD7-CAR-T-cell infusion in a child with Omicron COVID-19.
Journal: Blood science (Baltimore, Md.)
Published: May 24, 2023
Pomalidomide improves the effectiveness of CAR-T treatment in the relapsed and refractory multiple myeloma or B-cell leukemia/lymphoma with extramedullary disease.
Journal: Blood science (Baltimore, Md.)
Published: May 05, 2023
Therapeutic efficacy and infectious complications of CD19-targeted chimeric antigen receptor-modified T cell immunotherapy.
Journal: Anti-cancer drugs
Published: February 02, 2023
Last Updated: 09/26/2026